TR200102930T2 - Ruhsal bozuklukların tedavisinde yararlı olan ilaçların üretiminde osanetat kullanımı - Google Patents

Ruhsal bozuklukların tedavisinde yararlı olan ilaçların üretiminde osanetat kullanımı

Info

Publication number
TR200102930T2
TR200102930T2 TR2001/02930T TR200102930T TR200102930T2 TR 200102930 T2 TR200102930 T2 TR 200102930T2 TR 2001/02930 T TR2001/02930 T TR 2001/02930T TR 200102930 T TR200102930 T TR 200102930T TR 200102930 T2 TR200102930 T2 TR 200102930T2
Authority
TR
Turkey
Prior art keywords
treatment
mental disorders
osanetate
production
drugs useful
Prior art date
Application number
TR2001/02930T
Other languages
English (en)
Inventor
Emonds-Alt Xavier
Soubrie Philippe
Steinberg Regis
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of TR200102930T2 publication Critical patent/TR200102930T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Abstract

Mevcut bulus, ruhsal bozukluklarin özellikle de depresyonun tedavisinde kullanilmak üzere eczevi ürünlerin hazirlanmasinda osanetantin ve bunun farmasötik olarak kabul edilebilir tuzlarinin kullanimi ile ilgilidir.(Sekil yok)
TR2001/02930T 1999-04-13 2000-04-11 Ruhsal bozuklukların tedavisinde yararlı olan ilaçların üretiminde osanetat kullanımı TR200102930T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904699A FR2792199B3 (fr) 1999-04-13 1999-04-13 Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur

Publications (1)

Publication Number Publication Date
TR200102930T2 true TR200102930T2 (tr) 2002-04-22

Family

ID=9544412

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02930T TR200102930T2 (tr) 1999-04-13 2000-04-11 Ruhsal bozuklukların tedavisinde yararlı olan ilaçların üretiminde osanetat kullanımı

Country Status (24)

Country Link
US (1) US6420388B1 (tr)
EP (1) EP1175215A2 (tr)
JP (1) JP2002541190A (tr)
KR (1) KR20010105418A (tr)
CN (1) CN1354662A (tr)
AR (1) AR023452A1 (tr)
AU (1) AU3971600A (tr)
BR (1) BR0009704A (tr)
CA (1) CA2369638A1 (tr)
CZ (1) CZ20013645A3 (tr)
EE (1) EE200100527A (tr)
FR (1) FR2792199B3 (tr)
HR (1) HRP20010741A2 (tr)
HU (1) HUP0200655A3 (tr)
ID (1) ID30458A (tr)
IS (1) IS6098A (tr)
MX (1) MXPA01010340A (tr)
NO (1) NO20014953L (tr)
PE (1) PE20010032A1 (tr)
PL (1) PL351554A1 (tr)
SK (1) SK14552001A3 (tr)
TR (1) TR200102930T2 (tr)
WO (1) WO2000061125A2 (tr)
ZA (1) ZA200108289B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001095904A1 (en) * 2000-06-12 2001-12-20 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
WO2005061544A2 (en) * 2003-12-22 2005-07-07 Glaxo Group Limited Nogo-a neutralising immunoglobulins for treatment of neurological diseases
JP2007530591A (ja) * 2004-03-25 2007-11-01 スミスクライン・ビーチャム・コーポレイション 双極性障害を治療するための、ｎｋ３アンタゴニストの使用
EP1867717A4 (en) * 2005-03-15 2008-08-20 Sumitomo Chemical Co METHOD FOR REDUCE SYMPTOM CAUSED BY MUTUAL DISORDER
JP2006320201A (ja) * 2005-05-17 2006-11-30 Sumitomo Chemical Co Ltd 気分障害又は関連障害による疾患症状を改善させる方法
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
EP3915560A1 (en) 2014-06-25 2021-12-01 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) * 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
EP1175215A2 (fr) 2002-01-30
PL351554A1 (en) 2003-05-05
CZ20013645A3 (cs) 2002-01-16
NO20014953L (no) 2001-12-11
NO20014953D0 (no) 2001-10-11
US6420388B1 (en) 2002-07-16
AU3971600A (en) 2000-11-14
FR2792199A1 (fr) 2000-10-20
EE200100527A (et) 2002-12-16
IS6098A (is) 2001-09-28
ZA200108289B (en) 2002-12-24
SK14552001A3 (sk) 2002-02-05
AR023452A1 (es) 2002-09-04
CA2369638A1 (en) 2000-10-19
PE20010032A1 (es) 2001-04-11
HUP0200655A2 (hu) 2002-07-29
JP2002541190A (ja) 2002-12-03
KR20010105418A (ko) 2001-11-28
FR2792199B3 (fr) 2001-05-18
BR0009704A (pt) 2002-01-08
CN1354662A (zh) 2002-06-19
HUP0200655A3 (en) 2002-11-28
MXPA01010340A (es) 2002-05-06
ID30458A (id) 2001-12-06
WO2000061125A3 (fr) 2001-04-19
WO2000061125A2 (fr) 2000-10-19
HRP20010741A2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
DE60100866D1 (de) Cyklosporin, Hyaluronsäure und Polysorbate enthaltenes Augenarzneimittel
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
MXPA03007712A (es) Sales farmaceuticas.
ATE309798T1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
AU2002233288A1 (en) Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO
EE05109B1 (et) Sulfoonamiidi derivaadid, nende kasutamine meditsiinis ning meetod nende valmistamiseks
CA2431565A1 (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
MXPA04002714A (es) Uso de derivados de 2-oxo-1-pirrolidina para el tratamiento de trastornos del movimiento y de la discinesia.
DE60004797D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
TR200102930T2 (tr) Ruhsal bozuklukların tedavisinde yararlı olan ilaçların üretiminde osanetat kullanımı
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
HUP0202016A2 (en) Taxane derivatives, the use of them for producing anti-cancer medicaments, these medicaments and processes for preparation of these derivatives
EA200100802A1 (ru) Применение тианептина при приготовлении лекарственных средств, предназначенных для лечения нейродегенеративных патологий
HK1079981A1 (en) A pharmaceutical preparation comprising a abacavirand alovudine and use thereof
HUP0300345A2 (hu) Gyógyszerészeti termék
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
HK1050203A1 (en) Novel fusidic acid derivatives.
HUP0202888A2 (hu) Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény
GB0128071D0 (en) Medicament
BR9506507A (pt) Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao
PT1474415E (pt) Derivados de benzimidazol substituídos em 1-fenilo-2- heteroarilo, o seu uso para a produção de fármacos para o tratamento de doenças imunológicas